
CX-546 is the company code given for an ampakine compound by its developer, Cortex Pharmaceuticals. This compound comes right at the heels of cx-516, another ampakine compound that showed much promise as a treatment for ADHD during animal trials, but proved to be disappointing when it was tested on humans. This time around, the studies […]